Biospective Inc. is a specialty Contract Research Organization (CRO) with particular strengths in CNS diseases and disorders, including Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, ALS, Schizophrenia, and Depression. Our unique, state-of-the-art technologies and world-class scientific pre-clinical and clinical expertise accelerates the drug discovery timeline. Biospective provides industry-leading services in several cores areas: animal models and behavioral assays; animal imaging (NIGHTWING™ Platform), histology, and quantitative IHC (PERMITS™ Platform); and human MRI, fMRI, PET, and SPECT imaging (PIANO™ Platform). These platforms represent some of Biospective’s fully-automated, unbiased, and high-throughput technologies that provide sponsors with an unparalleled ability to assess the efficacy of their novel therapeutic agents throughout preclinical and clinical drug development.

Biotechnology

Clinical Trials

Health Care

Life Sciences

Research

Therapeutics

Biospective Inc.

Biospective Inc.'s headquarters in Montreal, Canada

Alan Evans

Andréa Hébert-Losier

Ramatoulaye Diallo

Alex Zijdenbos

Biospective Inc.

Org chart

Teams

Offices

Similar companies